Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

Overview of attention for article published in Journal of Clinical Oncology, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 41,562 followers.

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset http://t.co/C0tPiCBB #BCSM #BreastCancer

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset http://t.co/C0tPiCBB #bcsm #breastcancer

RT @TJH0828: Biology trumps other factors for predicting response to neoadjuvant chemotherapy #breastcancer #ISPY1 trial http://t.co/UKT ...

Pathologic Response Prediction of Survival Aided by #Tumor Type http://t.co/1uEub6hQ #cancer #oncology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.